New article from EHJ
|
7
|
Resverlogix Corp.
|
Jan 30, 2018 09:18AM
|
Re: Zenith Epigentics and Resverlogix update 22 Jan 2018
|
6
|
Zenith Epigenetics
|
Feb 01, 2018 12:14PM
|
Institutional buying??
|
5
|
Resverlogix Corp.
|
Feb 14, 2018 02:12PM
|
Re: Institutional buying??
|
3
|
Resverlogix Corp.
|
Feb 14, 2018 04:25PM
|
Zenith Private placement??
|
4
|
Zenith Epigenetics
|
Feb 20, 2018 10:15AM
|
Re: Zenith Private placement??
|
5
|
Zenith Epigenetics
|
Feb 21, 2018 10:26AM
|
Re: Statistical Considerations
|
5
|
Resverlogix Corp.
|
Mar 09, 2018 08:26AM
|
Re: Statistical Considerations
|
4
|
Resverlogix Corp.
|
Mar 09, 2018 10:50AM
|
188 Mace events?
|
4
|
Resverlogix Corp.
|
Mar 10, 2018 02:04PM
|
Re: Thought Provoking
|
7
|
Resverlogix Corp.
|
Mar 14, 2018 10:20AM
|
Re: BIO-Europe Presentation
|
4
|
Resverlogix Corp.
|
Mar 15, 2018 08:20AM
|
Re: RESVERLOGIX EXCEEDS FULL ENROLLMENT FOR THE PIVOTAL PHASE 3 BETONMACE CLINICAL TRIAL
|
4
|
Resverlogix Corp.
|
Mar 19, 2018 07:50AM
|
Re: time to add/3 vs 5 pt. MACE
|
5
|
Resverlogix Corp.
|
Mar 21, 2018 12:05PM
|
Re: time to add/3 vs 5 pt. MACE
|
1
|
Resverlogix Corp.
|
Mar 21, 2018 01:21PM
|
Re: Resverlogix Announces Two New Publications on Apabetalone in Kidney Disease
|
8
|
Resverlogix Corp.
|
Mar 28, 2018 08:00AM
|
Re: The Rubicon or the Jordan?
|
3
|
Resverlogix Corp.
|
Apr 10, 2018 04:45PM
|
Re: Resverlogix Announces US$30 Million Loan Commitment Letter .
|
6
|
Resverlogix Corp.
|
Apr 11, 2018 08:34AM
|
interesting article from todays National post
|
3
|
Resverlogix Corp.
|
Apr 14, 2018 03:23PM
|
Re: Cash burn and the cost of servicing the loan....
|
4
|
Resverlogix Corp.
|
Apr 16, 2018 12:42PM
|
Re: What if RRR MACE is significant at 90% confidence?
|
3
|
Resverlogix Corp.
|
Apr 24, 2018 10:33AM
|